Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Columbus, Ohio 43214


A Multicenter study to evaluation the safety and performance of Spectranetics Laser with Adjunct PTA and Gore Viabahn Endoprosthesis for the Treatment of SFA Instent Restenosis


Inclusion Criteria: - Subject or subject's legal representative informed of the study nature. - Subject understands the duration of the study and its follow up visit requirements. - Intermittent claudication extending through critical limb ischemia meeting a Rutherford 2-5 category. - Subject able to walk unassisted. - Female subjects of childbearing potential must have a negative serum pregnancy test 7 days prior to treatment. Exclusion Criteria: - Life expectancy less than 12 months - Myocardial infarction less than 3 months prior to procedure - Known allergies or sensitivities to heparin, aspirin, other anti-coagulant/antiplatelet therapies and nitinol. - Known allergy to contrast media that cannot adequately be pre-medicated prior to study procedure. - Uncontrolled hypercoagulability



Primary Contact:

Principal Investigator
Tony Das, MD
Presbyterian Heart Institute

Backup Contact:


Location Contact:

Columbus, Ohio 43214
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.